SYSGenomics Overview

  • Founded
  • 2014


  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

SYSGenomics General Information


Developer of molecular diagnostic tests intended for cancer patients. The company's platform is a molecular diagnostic test, enabling cancer patients and their oncologists to select treatment strategies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Decision/Risk Analysis
Other Industries
Primary Office
  • 51210 Lexingham Drive
  • Granger, IN 46530
  • United States
+1 (574) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SYSGenomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Jan-2023 Completed Startup
1. Accelerator/Incubator 03-Aug-2015 Completed Startup
To view SYSGenomics’s complete valuation and funding history, request access »

SYSGenomics Executive Team (3)

Name Title Board Seat Contact Info
Steven Buechler Ph.D Co-Founder
Sunil Badve MD Co-Founder
Yesim Gökmen-Polar Ph.D Co-Founder
To view SYSGenomics’s complete executive team members history, request access »